Kindred Biosciences (KIN) Misses Q1 EPS by 1c

Kindred Biosciences (NASDAQ: KIN) reported Q1 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• BofA cuts PG&E to Neutral as California wildfire reforms fall short
• Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance